• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Recommendations for SARS-CoV-2 Testing in Children With Disabilities and Medical Complexity

tetano

Editor, Senior Moderator
Pediatrics


. 2023 Jul 1;152(Suppl 1):e2022060352G.
doi: 10.1542/peds.2022-060352G. Recommendations for SARS-CoV-2 Testing in Children With Disabilities and Medical Complexity

Michael Gemmell[SUP] 1 [/SUP], Michael R Sherby[SUP] 1 [/SUP], Tyler J Walsh[SUP] 1 [/SUP], Luther G Kalb[SUP] 2 3 [/SUP], Sara B Johnson[SUP] 4 [/SUP], Ryan J Coller[SUP] 5 [/SUP], Gregory P DeMuri[SUP] 5 [/SUP], Erin Nuthals[SUP] 5 [/SUP], Joseph McBride[SUP] 5 [/SUP], Jason G Newland[SUP] 1 [/SUP], Christina A Gurnett[SUP] 1 [/SUP]



Affiliations
Abstract

Schools provide important services that cannot be provided virtually to children with medical complexity and children with intellectual and developmental disabilities, yet these children are among the most at risk from coronavirus disease 2019 (COVID-19). To keep schools open for children with medical complexity and/or intellectual and developmental disabilities during the COVID-19 pandemic, we implemented severe acute respiratory syndrome coronavirus 2 testing at 3 sites across the United States. We evaluated testing strategies for staff and students at each site, including specimen source (nasopharyngeal or saliva), test type (polymerase chain reaction or rapid antigen), and frequency and type (screening versus exposure/symptomatic) of testing provided. Among the greatest barriers to severe acute respiratory syndrome coronavirus 2 testing in these schools was the engagement of caregivers and challenges navigating legal guardianship for consenting adult students. Additionally, variability in testing strategies nationally and in the community, as well as surges in viral transmission across the United States during the course of the pandemic, led to testing hesitancy and variable participation rates. Essential to the successful implementation of testing programs is building a trusted relationship with school administrators and guardians. Leveraging our experiences with COVID-19 and forming lasting school partnerships can help keep schools for vulnerable children safe in future pandemics.


 
Back
Top Bottom